Lenvatinib Mesylate and Yellow fever vaccine Subcutaneous, Injection
Determining the interaction of Lenvatinib Mesylate and Yellow fever vaccine Subcutaneous, Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvatinib
Generic Name: yellow fever vaccine
Brand name: Stamaril, YF-Vax
Synonyms: Yellow fever vaccine, Yellow Fever Vaccine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lenvatinib Mesylate-Yervoy
- Lenvatinib Mesylate-Yescarta
- Lenvatinib Mesylate-YF-Vax
- Lenvatinib Mesylate-Yodoxin
- Lenvatinib Mesylate-Yohimbe
- Lenvatinib Mesylate-Yohimbine
- Yellow fever vaccine Subcutaneous, Injection-Lenvima
- Yellow fever vaccine Subcutaneous, Injection-Lenvima (14 MG Daily Dose)
- Yellow fever vaccine Subcutaneous, Injection-Lenvima (18 MG Daily Dose)
- Yellow fever vaccine Subcutaneous, Injection-Lenvima (20 MG Daily Dose)
- Yellow fever vaccine Subcutaneous, Injection-Lenvima (24 MG Daily Dose)
- Yellow fever vaccine Subcutaneous, Injection-Lenvima (8 MG Daily Dose)